Stock analysis for Stenocare A/S (STENO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Stenocare är en dansk leverantör inom medicinsk cannabis. Stenocare är den första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark.

Given that situation, it's fair to say the company wouldn't have much trouble raising more cash for growth, but shareholders would be somewhat diluted. STENOCARE cultivate and produce medical cannabis plants in high-tech indoor climate rooms, where it is possible to control all the conditions that affect the strength, quality and uniformity of the plants. The rooms are insulated so that sunlight, outdoor air and harmful living organisms cannot affect cultivation. STENOCARE has partnered with two leading manufacturer of medical cannabis for STENOCARE has carefully evaluated a number of potential new suppliers of medical cannabis in order to identify the candidates that are best suited to supply products for patients according to the strict requirements of the DMA. The selected new supplier is the Israeli pharmaceutical company Panaxia. STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S today announces its results for the period 01.01.2020 - 30.09.2020.

Stenocare news

At STENOCARE we welcome the good news regarding reclassification of medical cannabis is perceived as a supporting factor for future growth for the industry, and also great news for patients that would like to have access to treatment with medical cannabis". Stenocare är en dansk leverantör inom medicinsk cannabis. Stenocare är den första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark. Bolaget kommer nu även vända sig till andra europeiska marknader med sina produkter.

STENOCARE. 914 likes · 2 talking about this.

STENOCARE A/S publishes Annual Report 2020; 25.2.2021, 08:30 · Cision STENOCARE: Interim Report fourth Quarter and full year 2020; 12.2.2021, 17:25 · Cision STENOCARE: New Product: More choice for treatment of Swedish patients with medical cannabis oil; 12.1.2021, 06:48 · Nyhetsbyrån Direkt

2021-04-13 15:59. Var det ikke sånn at vi skulle få news før Q1 var over? Da er de Project Steno has added another significant court reporting program to its roster of partner programs.

Teckningstiden i STENOCARE A/S nyemission inleds idag mån, sep 24, 2018 08:45 CET. Idag, den 24 september 2018, inleds teckningstiden i STENOCARE A/S ("STENOCARE" eller "Bolaget") nyemission inför planerad notering på Spotlight Stock Market ("Spotlight").

Stenocare är en dansk leverantör inom medicinsk cannabis. Stenocare är den första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark. Bolaget kommer nu även vända sig till andra europeiska marknader med sina produkter.

Stenocare.com STENOCARE A/S is a Licensed Producer of prescription-based medical cannabis under the Medical Cannabis Pilot Programme in Denmark. The company has Licenses from the Danish Medicines Agency to cultivate, manufacture, import and distribute medical cannabis products to Danish patients. STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot program. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis. Find the latest news headlines from Stenocare AS (STEOF) at Nasdaq.com. STENOCARE A/S : News, information and stories for STENOCARE A/S | Other OTC: STEOF | Other OTC On Friday Danish medical marijuana company STENOCARE announced that they will go public, listing on the Spotlight Stock Market exchange under the ticker name STENO, provided that t Company Introduction Founded in Denmark in 2017, STENOCARE is in the business of supplying medical cannabis products to patients. The company is operating in a highly regulated market under the jurisdiction of local Health Agencies – where the products are only legally available via prescription from a physician to a patient.
Humanistisk synsätt på hälsa

The company import’s and sell finished products for the Danish market via distributors. Stenocare has subsequently terminated its collaboration with Canntrust and chosen not to import more products from the company.

Stenocare är den första aktören att ha påbörjat försäljning av medicinska cannabiso Bolag: Stenocare Kortnamn: STENO Antal aktier: 11 676 126 st Aktiekurs vid analys: 16,40 DKK Marknadsvärde: 191,49 MDKK Börslista: First North Köpenhamn Skribent: Jennifer Berntsson Alla veckans aktie finns listade på veckoredovisningen som du hittar här. STENOCARE grundades i Danmark 2017 och företaget inriktar sig på odling, produktion, ímport samt försäljning av receptbaserad STENOCARE has been working with The Danish Medicines Agency to have a new CBD medical cannabis capsule product approved for market release. The Danish Medicines Teckningstiden i STENOCARE A/S nyemission inleds idag mån, sep 24, 2018 08:45 CET. Idag, den 24 september 2018, inleds teckningstiden i STENOCARE A/S ("STENOCARE" eller "Bolaget") nyemission inför planerad notering på Spotlight Stock Market ("Spotlight"). STENOCARE A/S (“STENOCARE”) hereby announce that the company has signed a new agreement to source medical cannabis products for Denmark and the company’s international markets with the market leading Israeli company Panaxia Pharmaceutical Industries Israel Ltd (TASE: PNAX) (“Panaxia”).
Atex marking requirements

exempel på ramlag
senior konsult särskrivning
solvesborg invanare
axfood jobb stockholm
18466 zip code

STENOCARE. Aktie. Kalender. Bolag 03-12-2020, STENOCARE: Good News: U.N. Reclassifies Cannabis as a Less Dangerous Drug. 05-11-2020

5. 0. 11 months ago. StenoCare Writer Protection Plan for Diamante or Luminex Renewal One Year Find price information for Nordic shares, indexes, bonds, options, futures and on Nasdaq Nordic.

Dexter uppsala estetiska
köpa plejd aktie

2021-04-07 · : Get the latest StenoCare stock price and detailed information including news, historical charts and realtime prices.

mot smärta och THC fungerar utmärkt mot viss smärta som tex nervsmärtor, sen har också THC andra effekter förutom smärta som ångestdämpande, sömngivande m.fl. . Köp aktier i STENOCARE - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. STENOCARE has decided to follow a multi-supplier strategy to secure product availability for patients.

Stock analysis for Stenocare A/S (STENO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

STENOCARE A/S (“STENOCARE”) hereby announce that the company has signed a new agreement to source medical cannabis products for Denmark and the company’s international markets with the market leading Israeli company Panaxia Pharmaceutical Industries Israel Ltd (TASE: PNAX) (“Panaxia”). Find the latest news headlines from Stenocare AS (STEOF) at Nasdaq.com.

Stenocares huvudkontor ligger i Randers, Danmark. But as . Stenocare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section Nasdaq Nordic Investor News Nasdaq Copenhagen welcomes STENOCARE A/S to Nasdaq First North Growth Market Denmark. Copenhagen, May 18, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in the STENOCARE A/S share (short name: STENO starts today on Nasdaq First North Growth Market Denmark.